These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1662376)

  • 1. [Influence of HLA compatibility on cytomegalovirus infection in kidney transplantation].
    Pouteil-Noble C; Bétuel H; Raffaele P; Megri K; Louvier C; Lefrançois N; Bosshard S; Dubernard JM; Aymard M; Touraine JL
    Presse Med; 1991 Nov; 20(40):2022-4. PubMed ID: 1662376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus infection in renal transplant recipients: one center's experience.
    Bal Z; Uyar ME; Tutal E; Erdogan E; Colak T; Sezer S; Haberal M
    Transplant Proc; 2013; 45(10):3520-3. PubMed ID: 24314948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CMV infection after transplant from cord blood compared to other alternative donors: the importance of donor-negative CMV serostatus.
    Mikulska M; Raiola AM; Bruzzi P; Varaldo R; Annunziata S; Lamparelli T; Frassoni F; Tedone E; Galano B; Bacigalupo A; Viscoli C
    Biol Blood Marrow Transplant; 2012 Jan; 18(1):92-9. PubMed ID: 21689774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of HLA A-B-DR matching on cytomegalovirus disease after renal transplantation. Evidence that HLA-DR7-matched recipients are more susceptible to cytomegalovirus disease.
    Blancho G; Josien R; Douillard D; Bignon JD; Cesbron A; Soulillou JP
    Transplantation; 1992 Nov; 54(5):871-4. PubMed ID: 1332224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between HLA tissue type, CMV infection, and acute graft-vs-host disease after allogeneic hematopoietic stem cell transplantation: single-center experience.
    Kekik C; Besisik SK; Seyhun Y; Oguz FS; Sargin D; Carin MN
    Transplant Proc; 2009 Nov; 41(9):3859-62. PubMed ID: 19917401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of human cytomegalovirus viremia with human leukocyte antigens in liver transplantation recipients.
    Hu J; Meng X; Zhao H; Zhang X; Gao H; Yang M; Ma Y; Li M; Ma W; Fan J
    Acta Biochim Biophys Sin (Shanghai); 2011 Jul; 43(7):576-81. PubMed ID: 21680603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-DQ3 is a probable risk factor for CMV infection in high-risk kidney transplant patients.
    Varga M; Rajczy K; Telkes G; Hídvégi M; Péter A; Remport A; Korbonits M; Fazakas J; Toronyi E; Sárváry E; Kóbori L; Járay J
    Nephrol Dial Transplant; 2008 Aug; 23(8):2673-8. PubMed ID: 18332066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus infection--an etiological factor for rejection? A prospective study in 242 renal transplant patients.
    Pouteil-Noble C; Ecochard R; Landrivon G; Donia-Maged A; Tardy JC; Bosshard S; Colon S; Betuel H; Aymard M; Touraine JL
    Transplantation; 1993 Apr; 55(4):851-7. PubMed ID: 8386406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-A antigen incompatibility and HLA-B antigen compatibility associated with enhanced kidney allograft survival in blood-transfused patients.
    Bućin D
    Exp Clin Immunogenet; 1986; 3(3):138-44. PubMed ID: 3274633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA mismatching and cytomegalovirus infection as risk factors for transplant failure in cyclosporin-treated renal allograft recipients.
    Morris DJ; Martin S; Dyer PA; Hunt L; Mallick NP; Johnson RW
    J Med Virol; 1993 Dec; 41(4):324-7. PubMed ID: 8106868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomegalovirus (CMV) excretion as a factor in the severity of CMV disease in kidney and simultaneous kidney and pancreas transplantation.
    Pouteil-Noble C; Ecochard R; Bosshard S; Lacavalerie B; Donia A; Landrivon G; Tardy JC; Dubernard JM; Aymard M; Touraine JL
    Transpl Int; 1992; 5 Suppl 1():S26-9. PubMed ID: 14621724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA compatibility index: does it have a role in patients after heart transplantation?
    Bedanova H; Orban M; Ondrasek J; Stepanova R; Nemec P
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Mar; 157(1):5-11. PubMed ID: 23446213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-DRB1*09 is associated with increased incidence of cytomegalovirus infection and disease after allogeneic hematopoietic stem cell transplantation.
    Du J; Liu J; Gu J; Zhu P
    Biol Blood Marrow Transplant; 2007 Dec; 13(12):1417-21. PubMed ID: 18022570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Factors influencing prevalence and clinical course of cytomegalovirus (CMV) infection in kidney transplant patients].
    Szymczakiewicz-Multanowska AM; Kuźniewski M; Zawilińska B; Zgórniak-Nowosielska I; Uracz D; Ignacak E; Betkowska-Prokop A; Sułowicz W
    Przegl Lek; 2001; 58(7-8):772-7. PubMed ID: 11769385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simpler and equitable allocation of kidneys from postmortem donors primarily based on full HLA-DR compatibility.
    Doxiadis II; de Fijter JW; Mallat MJ; Haasnoot GW; Ringers J; Persijn GG; Claas FH
    Transplantation; 2007 May; 83(9):1207-13. PubMed ID: 17496537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of HLA matching on cytomegalovirus hepatitis and chronic rejection after liver transplantation.
    Mañez R; White LT; Linden P; Kusne S; Martin M; Kramer D; Demetris AJ; Van Thiel DH; Starzl TE; Duquesnoy RJ
    Transplantation; 1993 May; 55(5):1067-71. PubMed ID: 8388584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation.
    Ricart MJ; Malaise J; Moreno A; Crespo M; Fernández-Cruz L;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii25-ii32, ii62. PubMed ID: 15814546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of HLA-DR on T lymphocytes following renal transplantation, and association with graft-rejection episodes and cytomegalovirus infection.
    van Es A; Baldwin WM; Oljans PJ; Tanke HJ; Ploem JS; van Es LA
    Transplantation; 1984 Jan; 37(1):65-9. PubMed ID: 6320508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive donor/recipient CMV status is not a detrimental factor for renal allograft/patient survival.
    Krishnan G; Vaughn WK; Capelli JP; Glass NR
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1485-6. PubMed ID: 8382877
    [No Abstract]   [Full Text] [Related]  

  • 20. The impact of HLA-DR incompatibilities on kidney graft function and on the number of rejection treatments. The Dutch Study Group of Renal Transplantation.
    Groenewoud AF
    Transplant Proc; 1987 Feb; 19(1 Pt 1):683-4. PubMed ID: 3274840
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.